Discovery of G-CSF and early clinical studies

Twenty Years of G-CSF: Clinical and Nonclinical Discoveries

Volumn , Issue , 2012, Pages 15-24

  Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895065126     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-0348-0218-5_2     Document Type: Chapter

References (37)

1. Metcalf D (2010) The colony-stimulating factors and cancer. Nat Rev Cancer 10:425-434.
2. Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. J Biol Chem 258:9017-9023.
3. Welte K, Platzer E, Lu I et al (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A 82:1526-1530.
4. Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MA (1982) Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. J Exp Med 156:454-464.
5. Ihle JN, Keller J, Henderson L, Klein F, Palaszynski E (1982) Procedures for the purification of interleukin 3 to homogeneity. J Immunol 129:2431-2436.
6. Souza LM, Boone TC, Gabrilove J et al (1986) Recombinant human granulocyte colonystimulating factor: effects on normal and leukemic myeloid cells. Science 232:61-65.
7. Nomura H, Imazeki I, Oheda M et al (1986) Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J 5:871-876.
8. Nagata S, Tsuchiya M, Asano S et al (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415-418.
9. Fukunaga R, Ishizaka-Ikeda E, Nagata S (1990) Purification and characterization of the receptor for murine granulocyte-colony-stimulating factor. J Biol Chem 265:14008-14015.
10. Skokowa J, Cario G, UenalanMet al (2006) LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 12:1191-1197.
11. Skokowa LD, Thakur BK et al (2009) NAMPT is essential for the G-CSF induced myeloid differentiation via NAD+-sirtuin-1-dependent pathway. Nat Med 15:151-158.
12. Platzer E, Welte K, Gabrilove JL et al (1985) Biological activities of a human pluripotent hematopoietic colony stimulating factor on normal and leukemic cells. J Exp Med 162:1788-1801.
13. Strife A, Lambek C, Wisniewski D et al (1987) Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells. Blood 69:1508-1523.
14. Lieschke GJ, Grail D, Hodgson G et al (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737-1746.
15. Welte K, Bonilla MA, Gillio AP et al (1987) Recombinant human granulocyte colonystimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165:941-948.
16. Gillio AP, Bonilla MA, Potter GK et al (1987) Effects of recombinant human granulocyte colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Transplant Proc 19:153.
17. Gabrilove JL, Jakubowski A, Scher H et al (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422.
18. Bronchud MH, Scarfe JH, Thatcher N et al (1987) Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809-813.
19. Crawford J, Ozer H, Stoller R et al (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170.
20. Trillet-Lenoir V, Green J, Manegold C et al (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29A:319-324.
21. Lowenberg B, Touw IT (1993) Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281-292.
22. Ohno R, Naoe T, Kanamaru A et al (1994) A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood 83:2015-2019.
23. Estey E, Thall P, Andreeff M et al (1994) Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol 12:671-678.
24. Giralt S, Escudier S, Kantarjian H et al (1993) Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med 329:757-761.
25. Welte K, Reiter A, Mempel K et al (1996) A randomized phase III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood 87:3143-3150.
26. Taylor KM, Jagganath S, Spitzer G et al (1989) Recombinant human granulocyte colonystimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7:1791-1799.
27. Sheridan WP, Morstyn G, Wolf M et al (1989) Granulocyte colony stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895.
28. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081.
29. Sheridan WP, Begley CG, Juttner CA et al (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644.
30. De Luca E, Sheridan WP, Watson D, Szer J, Begley CG (1992) Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 66:893-899.
31. Bensinger W, Singer J, Appelbaum F et al (1993) Autologous transplantation with peripheral blood progenitor mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158-3163.
32. Bonilla MA, Gillio AP, Ruggeiro M et al (1989) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320:1574-1580.
33. Welte K, Zeidler C, Reiter A et al (1990) Differential effects of granulocyte-macrophage colony stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75:1056-1063.
34. Dale DC, Bonilla MA, Davis MS et al (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496-2502.
35. Bonilla MA, Dale D, Zeidler C et al (1994) Long-term safety of treatment with recombinant human granulocyte colony stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723-730.
36. Welte K, Zeidler C, Dale DC (2006) Severe congenital neutropenia. Semin Hematol 43:189-195.
37. Zeidler C, GermeshausenM, Klein C, Welte K (2009) Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 144:459-467.